Fundz

JenaValve Appoints Edward Sarnowski as Chief Technology Officer

PRIVATEMay 28, 2026

Position

Chief Technology Officer

Company

JenaValve

Edward Sarnowski
IrvineManufacturingInformation TechnologyBiotechnologyHealthcareHealth CareMedical Device

Description

JenaValve has appointed Edward (Ed) Sarnowski as its new Chief Technology Officer. He will lead the R&D organization and drive innovation for the company's transcatheter aortic valve programs.

Quick answer

JenaValve Appoints Edward Sarnowski as Chief Technology Officer (May 28, 2026). JenaValve is based in Irvine, California, United States.

Who is the new Chief Technology Officer at JenaValve?
JenaValve named Edward Sarnowski Chief Technology Officer, announced May 28, 2026.
What did JenaValve announce on May 28, 2026?
JenaValve has appointed Edward (Ed) Sarnowski as its new Chief Technology Officer. He will lead the R&D organization and drive innovation for the company's transcatheter aortic valve programs.
What does JenaValve do?
JenaValve is a medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of aortic regurgitation (AR).
Where is JenaValve based?
JenaValve is based in Irvine, California, United States.
Which similar companies made leadership changes around the same time?
NOWDiagnostics, Inc. (May 28, 2026), Edwards Lifesciences (May 5, 2026), NuVision Biotherapies (May 26, 2026) and Poly Medicure (June 2, 2026) also announced leadership changes within 45 days of JenaValve.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Medical Device

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at JenaValve, and when

A new leader at JenaValve brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day JenaValve raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at JenaValve, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at JenaValve. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

JenaValve

Location

Irvine, California, United States

About

JenaValve is a medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of aortic regurgitation (AR). The JenaValve Trilogy Heart Valve System is the first and only device currently approved in the EU for the treatment of severe, symptomatic aortic regurgitation in patients that are deemed high-risk for surgical aortic valve replacement. The Trilogy System is also CE-Mark approved for treatment of severe, symptomatic aortic stenosis. In the US, JenaValve has completed enrollment of the ALIGN-AR IDE Clinical Trial which will support a future PMA submission. If approved, the Trilogy System would become the first and only TAVR system in the US indicated for the treatment of symptomatic, severe AR.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment JenaValve changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

John
Senior decision-maker at this company
••••••••@••••••••

See John's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for JenaValve's next move

Learn about Strategic plan

JenaValve changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.